Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 3
1987 3
1988 2
1989 1
1990 4
1991 4
1992 5
1993 3
1994 1
1995 6
1996 8
1997 8
1998 12
1999 14
2000 15
2001 15
2002 11
2003 19
2004 16
2005 9
2006 11
2007 6
2008 10
2009 14
2010 17
2011 11
2012 25
2013 23
2014 30
2015 35
2016 38
2017 33
2018 31
2019 35
2020 33
2021 36
2022 25
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

549 results

Results by year

Filters applied: . Clear all
Page 1
A Test in Context: D-Dimer.
Weitz JI, Fredenburgh JC, Eikelboom JW. Weitz JI, et al. J Am Coll Cardiol. 2017 Nov 7;70(19):2411-2420. doi: 10.1016/j.jacc.2017.09.024. J Am Coll Cardiol. 2017. PMID: 29096812 Free article. Review.
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.
Bejjani A, Khairani CD, Assi A, Piazza G, Sadeghipour P, Talasaz AH, Fanikos J, Connors JM, Siegal DM, Barnes GD, Martin KA, Angiolillo DJ, Kleindorfer D, Monreal M, Jimenez D, Middeldorp S, Elkind MSV, Ruff CT, Goldhaber SZ, Krumholz HM, Mehran R, Cushman M, Eikelboom JW, Lip GYH, Weitz JI, Lopes RD, Bikdeli B. Bejjani A, et al. Among authors: weitz ji. J Am Coll Cardiol. 2024 Jan 23;83(3):444-465. doi: 10.1016/j.jacc.2023.10.038. J Am Coll Cardiol. 2024. PMID: 38233019 Review.
News at XI: moving beyond factor Xa inhibitors.
Fredenburgh JC, Weitz JI. Fredenburgh JC, et al. Among authors: weitz ji. J Thromb Haemost. 2023 Jul;21(7):1692-1702. doi: 10.1016/j.jtha.2023.04.021. Epub 2023 Apr 26. J Thromb Haemost. 2023. PMID: 37116752 Review.
Venous thrombosis.
Wolberg AS, Rosendaal FR, Weitz JI, Jaffer IH, Agnelli G, Baglin T, Mackman N. Wolberg AS, et al. Among authors: weitz ji. Nat Rev Dis Primers. 2015 May 7;1:15006. doi: 10.1038/nrdp.2015.6. Nat Rev Dis Primers. 2015. PMID: 27189130 Review.
Prosthetic Heart Valve Thrombosis.
Dangas GD, Weitz JI, Giustino G, Makkar R, Mehran R. Dangas GD, et al. Among authors: weitz ji. J Am Coll Cardiol. 2016 Dec 20;68(24):2670-2689. doi: 10.1016/j.jacc.2016.09.958. J Am Coll Cardiol. 2016. PMID: 27978952 Free article. Review.
Apixaban for extended treatment of venous thromboembolism.
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI; AMPLIFY-EXT Investigators. Agnelli G, et al. Among authors: weitz ji. N Engl J Med. 2013 Feb 21;368(8):699-708. doi: 10.1056/NEJMoa1207541. Epub 2012 Dec 8. N Engl J Med. 2013. PMID: 23216615 Free article. Clinical Trial.
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Ruff CT, et al. Among authors: weitz ji. Lancet. 2014 Mar 15;383(9921):955-62. doi: 10.1016/S0140-6736(13)62343-0. Epub 2013 Dec 4. Lancet. 2014. PMID: 24315724
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. Among authors: weitz ji. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review.
Bikdeli B, Zahedi Tajrishi F, Sadeghipour P, Talasaz AH, Fanikos J, Lippi G, Siegal DM, Eikelboom JW, Monreal M, Jimenez D, Connors JM, Ageno W, Barnes GD, Piazza G, Angiolillo DJ, Parikh SA, Kirtane AJ, Lopes RD, Bhatt DL, Weitz JI, Mehran R, Krumholz HM, Goldhaber SZ, Lip GYH. Bikdeli B, et al. Among authors: weitz ji. JAMA Cardiol. 2022 Jul 1;7(7):747-759. doi: 10.1001/jamacardio.2022.1292. JAMA Cardiol. 2022. PMID: 35648414 Review.
549 results